180 Life Sciences (ATNF) Short Interest Ratio & Short Volume $1.00 +0.01 (+1.01%) As of 03:47 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock 180 Life Sciences Short Interest Data180 Life Sciences (ATNF) has a short interest of 72,600 shares, representing 13.12% of the float (the number of shares available for trading by the public). This marks a -21.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 798,400 shares to cover all short positions.Current Short Interest72,600 sharesPrevious Short Interest92,200 sharesChange Vs. Previous Month-21.26%Dollar Volume Sold Short$74.05 thousandShort Interest Ratio0.6 Days to CoverLast Record DateMay 31, 2025Outstanding Shares5,695,000 sharesFloat Size553,500 sharesShort Percent of Float13.12%Today's Trading Volume9,609 sharesAverage Trading Volume798,400 sharesToday's Volume Vs. Average1% Short Selling 180 Life Sciences? Sign up to receive the latest short interest report for 180 Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATNF Short Interest Over TimeATNF Days to Cover Over TimeATNF Percentage of Float Shorted Over Time 180 Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202572,600 shares $74.05 thousand -21.3%13.1%0.6 $1.02 5/15/202592,200 shares $107.87 thousand +4.0%22.3%0.6 $1.17 4/30/202588,700 shares $78.94 thousand -25.7%21.5%0.6 $0.89 4/15/2025119,300 shares $106.18 thousand +107.8%13.0%1.3 $0.89 3/31/202557,400 shares $58.84 thousand +2.5%4.2%0.4 $1.03 3/15/202556,000 shares $59.92 thousand +67.2%4.1%0.1 $1.07 2/28/202533,500 shares $39.20 thousand +29.3%2.4%0.1 $1.17 2/15/202525,900 shares $34.45 thousand -50.4%1.5%0.1 $1.33 1/31/202552,200 shares $73.08 thousand -63.2%3.1%0.1 $1.40 1/15/2025141,800 shares $232.55 thousand +11.7%8.4%0.2 $1.64 Get the Latest News and Ratings for ATNF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 12/31/2024126,900 shares $230.96 thousand -21.1%7.6%0.1 $1.82 12/15/2024160,800 shares $310.34 thousand +148.2%31.4%0.1 $1.93 11/30/202464,800 shares $144.50 thousand -28.6%13.2%0 $2.23 11/15/202490,800 shares $227 thousand -34.9%18.5%0 $2.50 10/31/2024139,400 shares $546.45 thousand +77.1%28.5%0.1 $3.92 10/15/202478,700 shares $119.62 thousand +7.4%16.1%0 $1.52 9/30/202473,300 shares $123.88 thousand +21.0%14.1%0.8 $1.69 9/15/202460,600 shares $109.69 thousand +78.8%11.7%0.1 $1.81 8/31/202433,900 shares $61.36 thousand +5.3%6.5%0.1 $1.81 8/15/202432,200 shares $60.54 thousand -29.7%6.2%0.1 $1.88 7/31/202445,800 shares $95.26 thousand -67.5%8.8%0.1 $2.08 7/15/2024140,800 shares $285.82 thousand +249.4%27.2%0.2 $2.03 6/30/202440,300 shares $66.50 thousand +13.2%7.8%0.1 $1.65 6/15/202435,600 shares $55.18 thousand -19.8%6.9%0.3 $1.55 5/31/202444,400 shares $71.93 thousand +156.7%8.6%0.3 $1.62 5/15/202417,300 shares $33.56 thousand -36.9%3.4%0.1 $1.94 4/30/202427,400 shares $58.91 thousand +60.2%5.3%0.3 $2.15 4/15/202417,100 shares $34.54 thousand -59.7%3.3%0.2 $2.02 3/31/202442,400 shares $98.79 thousand -31.4%8.4%0.4 $2.33 3/15/202461,800 shares $216.30 thousand +309.3%12.2%0.6 $3.50 2/29/202415,100 shares $53.15 thousand -95.6%3.0%0.2 $3.52 2/15/2024342,100 shares $1.36 million -22.8%3.6%0.3 $3.99 1/31/2024443,300 shares $94.87 thousand -61.8%4.6%0.4 $0.21 1/15/20241,160,000 shares $234.55 thousand +195.7%12.2%1 $0.20 12/31/2023392,300 shares $83.76 thousand -32.9%4.1%0.4 $0.21 12/15/2023584,700 shares $109.92 thousand -4.0%6.2%1 $0.19 11/30/2023608,900 shares $165.01 thousand +281.3%8.8%1.2 $0.27 11/15/2023159,700 shares $57.48 thousand +26.1%2.3%1.2 $0.36 10/31/2023126,700 shares $54.48 thousand +21.2%2.3%0.9 $0.43 10/15/2023104,500 shares $58.51 thousand -37.3%1.9%0.3 $0.56Get Ready for Elon Musk’s BIGGEST Comeback Yet (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 9/30/2023166,700 shares $102.10 thousand +64.7%3.0%0.5 $0.61 9/15/2023101,200 shares $83.71 thousand -30.1%1.8%0.3 $0.83 8/31/2023144,800 shares $96.58 thousand -77.1%2.6%0.5 $0.67 8/15/2023632,100 shares $453.85 thousand +3,108.6%11.2%1.9 $0.72 7/31/202319,700 shares $18.52 thousand -34.8%0.4%0 $0.94 7/15/202330,200 shares $31.41 thousand -46.4%0.6%0.1 $1.04 6/30/202356,300 shares $65.87 thousand -52.3%1.1%0.1 $1.17 6/15/2023118,000 shares $136.88 thousand -27.4%2.4%0.1 $1.16 5/31/2023162,500 shares $185.25 thousand +70.3%3.4%0.2 $1.14 5/15/202395,400 shares $98.26 thousand -13.2%2.0%0.1 $1.03 4/30/2023109,900 shares $126.39 thousand -51.7%2.4%0.2 $1.15 4/15/2023227,500 shares $282.10 thousand +106.6%7.2%0.2 $1.24 3/31/2023110,100 shares $198.18 thousand +56.0%3.5%0.1 $1.80 3/15/202370,600 shares $146.14 thousand -59.2%4.6%0 $2.07 2/28/2023173,000 shares $496.51 thousand -7.2%11.2%0 $2.87 2/15/2023186,400 shares $561.06 thousand -52.7%11.2%0 $3.01 1/31/2023393,900 shares $1.31 million -26.6%23.6%0.1 $3.33 1/15/2023536,900 shares $1.99 million +3.0%32.2%0.1 $3.71 12/30/2022521,100 shares $1.77 million +1,060.6%31.2%0.1 $3.39 12/15/202244,900 shares $243.99 thousand -94.9%2.8%0.1 $5.43 11/30/2022874,900 shares $367.46 thousand -0.2%N/A4.4 $0.42 11/15/2022876,800 shares $380.88 thousand -3.4%N/A4.6 $0.43 10/31/2022907,300 shares $424.80 thousand -11.1%N/A4.2 $0.47 10/15/20221,020,000 shares $520.40 thousand +1.0%N/A4.9 $0.51 9/30/20221,010,000 shares $671.65 thousand +2.0%N/A4.7 $0.67 9/15/2022990,000 shares $802.00 thousand -2.0%N/A5.6 $0.81 8/31/20221,010,000 shares $859.91 thousand +9.8%N/A4.7 $0.85 8/15/2022919,500 shares $1.05 million -1.7%N/A3.4 $1.14 7/31/2022935,700 shares $1.02 million +3.9%N/A3.3 $1.09 7/15/2022900,500 shares $1.03 million -8.0%N/A2 $1.14 6/30/2022978,400 shares $829.68 thousand -13.4%N/A2.1 $0.85 6/15/20221,130,000 shares $998.92 thousand -18.7%N/A2.3 $0.88 5/31/20221,390,000 shares $2.25 million -0.7%N/A3.2 $1.62 5/15/20221,400,000 shares $1.76 million +5.3%N/A3.6 $1.26 4/30/20221,330,000 shares $2.82 million -1.5%N/A3.4 $2.12 4/15/20221,350,000 shares $2.65 million -6.3%N/A4.7 $1.96 3/31/20221,440,000 shares $3.73 million -4.0%N/A4.6 $2.59 3/15/20221,500,000 shares $3.87 million +5.6%N/A4.2 $2.58 2/28/20221,420,000 shares $4.53 million -6.6%N/A2.9 $3.19 2/15/20221,520,000 shares $4.97 million +13.4%N/A1.8 $3.27 1/31/20221,340,000 shares $3.83 million -8.8%N/A1.4 $2.86 1/15/20221,470,000 shares $4.47 million -7.0%N/A1.5 $3.04 12/31/20211,580,000 shares $6.16 million -18.1%N/A1.6 $3.90 12/15/20211,930,000 shares $7.86 million +37.9%N/A2 $4.07 11/30/20211,400,000 shares $8.93 million +2.2%N/A1.3 $6.38 11/15/20211,370,000 shares $5.86 million -16.0%N/A1.8 $4.28 10/29/20211,630,000 shares $8.26 million +16.4%N/A2.4 $5.07 10/15/20211,400,000 shares $7.85 million -4.8%N/A1.9 $5.61 9/30/20211,470,000 shares $7.95 million -33.8%N/A2.1 $5.41 9/15/20212,220,000 shares $14.65 million +14.4%N/A3.3 $6.60Get Ready for Elon Musk’s BIGGEST Comeback Yet (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 8/31/20211,940,000 shares $11.43 million +116.6%N/A3.9 $5.89 8/13/2021895,800 shares $6.96 million -60.5%N/A2 $7.77 7/30/20212,270,000 shares $17.18 million +3.2%20.3%5.7 $7.57 7/15/20212,200,000 shares $20.17 million -0.5%19.7%5.7 $9.17 6/30/20212,210,000 shares $22.10 million -1.3%24.2%1.7 $10.00 6/15/20212,240,000 shares $22.92 million +2.8%24.6%1 $10.23 5/28/20212,180,000 shares $18.62 million -15.5%23.9%0.9 $8.54 5/14/20212,580,000 shares $17.67 million -9.8%28.3%1 $6.85 4/30/20212,860,000 shares $29.66 million -5.6%31.4%1.1 $10.37 4/15/20213,030,000 shares $31.69 million +25.7%33.2%1 $10.46 3/31/20212,410,000 shares $14.80 million +6.2%26.4%0.8 $6.14 3/15/20212,270,000 shares $14.48 million +6.1%83.5%1.3 $6.38 2/26/20212,140,000 shares $9.44 million +364.0%78.7%1.3 $4.41 2/12/2021461,200 shares $2.73 million +54.6%17.0%0.3 $5.91 1/29/2021298,300 shares $1.04 million -1.8%11.0%0.2 $3.48 1/15/2021303,900 shares $948.17 thousand No Change11.2%0.3 $3.12 ATNF Short Interest - Frequently Asked Questions What is 180 Life Sciences' current short interest? Short interest is the volume of 180 Life Sciences shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 72,600 shares of ATNF short. 13.12% of 180 Life Sciences' shares are currently sold short. Learn More on 180 Life Sciences' current short interest. What is a good short interest ratio for 180 Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATNF shares currently have a short interest ratio of 1.0. Learn More on 180 Life Sciences's short interest ratio. What is a good short interest percentage for 180 Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.12% of 180 Life Sciences' floating shares are currently sold short. Is 180 Life Sciences' short interest increasing or decreasing? 180 Life Sciences saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 72,600 shares, a decrease of 21.3% from the previous total of 92,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is 180 Life Sciences' float size? 180 Life Sciences currently has issued a total of 5,695,000 shares. Some of 180 Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 180 Life Sciences currently has a public float of 553,500 shares. How does 180 Life Sciences' short interest compare to its competitors? 13.12% of 180 Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 180 Life Sciences: X4 Pharmaceuticals, Inc. (10.28%), Cyclo Therapeutics, Inc. (3.55%), Ovid Therapeutics Inc. (2.79%), Imunon, Inc. (33.31%), CytoMed Therapeutics Limited (1.24%), CASI Pharmaceuticals, Inc. (0.47%), Lisata Therapeutics, Inc. (0.42%), Enlivex Therapeutics Ltd. (0.53%), Q32 Bio Inc. (10.35%), MIRA Pharmaceuticals, Inc. (1.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short 180 Life Sciences stock? Short selling ATNF is an investing strategy that aims to generate trading profit from 180 Life Sciences as its price is falling. ATNF shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 180 Life Sciences? A short squeeze for 180 Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATNF, which in turn drives the price of the stock up even further. How often is 180 Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATNF, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies X4 Pharmaceuticals Short Squeeze Cyclo Therapeutics Short Squeeze Ovid Therapeutics Short Squeeze Imunon Short Squeeze CytoMed Therapeutics Short Squeeze CASI Pharmaceuticals Short Squeeze Lisata Therapeutics Short Squeeze Enlivex Therapeutics Short Squeeze Q32 Bio Short Squeeze MIRA Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATNF) was last updated on 6/12/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
